Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1394 of 5804
-
New pill targets hard-to-treat cancers with KRAS G12D mutation
Disease control Recruiting nowThis study is conducted to determine the safety and tolerability of INCB161734 as a single agent or in combination with other anticancer therapies.
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Blue light hope for postpartum depression
Symptom relief Recruiting nowDepression and anxiety are significant public health issues during pregnancy and the postnatal period, particularly affecting those in developing countries. Disruptions in biological rhythms, sleep problems, and low exposure to daylight are associated with a higher risk of these …
Phase: NA • Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New pneumonia vaccine shows promise in early trial for kids
⭐️ VACCINE ⭐️ CompletedA phase 1b clinical trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) developed by Sinovac Life Science Co., Ltd will be conducted in children aged 2 months (42-89 days) and 2 to 5 years. The objective of the study is to evaluate the safety and immunogenici…
Phase: PHASE1 • Sponsor: Sinovac Research and Development Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC
-
Could a bile acid blocker prevent esophageal cancer?
Disease control Recruiting nowThis phase II trial studies the effect of obeticholic acid in treating patients with Barrett's esophagus. Bile acids present in duodenogastroesophageal reflux contribute to neoplastic progression in Barrett's esophagus. Obeticholic acid has shown anti-cholestatic, anti-inflammato…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for duchenne? experimental drug BMN 351 enters human testing
Disease control OngoingThe purpose of this study is to test the safety and tolerability of BMN 351 in participants with Duchenne Muscular Dystrophy (DMD) with a genetic mutation amenable to exon 51 skipping.
Phase: PHASE1, PHASE2 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New immunotherapy cocktail targets tough colon cancer
Disease control Recruiting nowEvaluate the objective response rate (ORR) of AK104 combined with chemotherapy and cetuximab or bevacizumab in second-line treatment of MSS type advanced colorectal cancer
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New program aims to keep hospital patients on track for opioid and meth recovery
Disease control OngoingPolysubstance use involving opioids and methamphetamine is emerging as a new public health crisis. Patients with opioids and methamphetamine use often experience serious medical complications requiring hospitalization, which provides an opportunity to offer addiction treatment. Y…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New wrap could save kidney patients from dialysis disasters
Disease control Recruiting nowThis is a prospective, randomized, multi-center clinical trial for chronic kidney disease (CKD) patients referred for creation of a new arteriovenous fistula (AVF) in order to assess the safety and effectiveness of SelfWrap, a bioabsorbable perivascular wrap.
Phase: NA • Sponsor: VenoStent • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for rare blood disorder: experimental antibody EA5 enters human testing
Disease control Recruiting nowThis is a multicenter, open-label, Phase Ib clinical trial designed to evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of multiple doses of the humanized monoclonal antibody EA5 in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).
Phase: PHASE1 • Sponsor: Shanghai Lanyi Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Dietitian support may cut insulin need in pregnancy diabetes
Disease control CompletedThe treatment of gestational diabetes (GDM) primarily revolves around consuming an optimal diet that does not cause blood glucose levels to become excessively high and provides an adequate supply of micro- and macronutrients without resulting in excessive weight gain during pregn…
Phase: NA • Sponsor: Steno Diabetes Center Copenhagen • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New chemo delivery method targets pancreatic cancer before surgery
Disease control OngoingThis is a window-of-opportunity study which will evaluate the safety and feasibility of single-dose neoadjuvant Hepatic Artery (HA) chemotherapy (FUDR/oxaliplatin) in patients with localized pancreatic ductal adenocarcinoma (PDAC) eligible for surgical resection and systemic chem…
Phase: PHASE4 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New PET tracer could sharpen detection of aggressive breast cancer
Diagnosis Recruiting nowThis is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the clinical predictive value of 68Ga-DOTA-BPP in subjects with triple-negative breast cancer. The visual and semiquantitative methods will be used to assess the PET/CT images
Sponsor: Peking University Cancer Hospital & Institute • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
Stem cell showdown: donor vs. your own fat for Crohn's fistulas
Disease control Recruiting nowOne of the newest and most innovative medicinal approaches is cell therapy. Several clinical trials and experimental investigations have looked into the feasibility of treating CD-related fistulas with stem cells. The current indication for ALOFISEL® (active ingredient: Darvadst…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
700 migraine patients tracked to see how well newer drugs really work
Disease control Recruiting nowThe goal of this observational study is to evaluate clinical differences in patients who received preventive treatment with medication targeting calcitonin gene-related peptide (CGRP) or its receptor: monoclonal antibodies (erenumab, galcanezumab, fremanezumab, eptinezumab) or ge…
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Disease control
Last updated Jun 26, 2026 14:59 UTC
-
Zapping away migraines: brain stimulation shows promise for chronic sufferers
Symptom relief CompletedThis randomized, double-blind, sham-controlled clinical trial aims to evaluate the efficacy of non-invasive brain stimulation as an add-on treatment to standard detoxification therapy in patients with chronic migraine and medication overuse. The study also seeks to identify senso…
Phase: NA • Sponsor: IRCCS National Neurological Institute "C. Mondino" Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Can early action tame hidden heart flutters?
Disease control Recruiting nowThe goal of this study to find out the efficacy of early rhythm therapy in patients with subclinical atrial fibrillation detected by Cardiac Electronic Implantable Devices. Early rhythm therapy includes antiarrhythmic drug, cardioversion, and catheter ablation. The general contr…
Phase: NA • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Magnetic heart fix: new device targets dangerous rhythms
Disease control Recruiting nowThe purpose of the first phase of this feasibility study is to gather safety and performance data on MAGiC to support European marketing approval. The purpose of MAGiC-FEST PMCF Study is to collect safety and performance data with MAGiC to meet ongoing regulatory obligations.
Phase: NA • Sponsor: Stereotaxis • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New algorithm could save thousands of children after sepsis hospital stays
Knowledge-focused Recruiting nowThis study is an observational multi-country cohort study that aims to build algorithms that can identify children between 5 and 16 years of age admitted for proven or suspected sepsis who are at risk of mortality after they are discharged in East Africa. In low- and middle-inco…
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Breathing easy: dynamic x-rays may spot COPD faster and safer
Diagnosis Recruiting nowThe prevalence of chronic obstructive pulmonary disease (COPD) is on the rise, leading to an increasing economic and social burden. Currently, the diagnosis and staging of COPD heavily rely on pulmonary function testing. However, limitations such as patient cooperation and comorb…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
Stem cell shot aims to save limbs in rare artery disease
Disease control Recruiting nowThe goal of this observational, practice-based feasibility study is to observe the efficacy and safety of intramuscular administration of Stempeucel® in Malaysian patients with critical limb ischemia (CLI) due to Buerger's disease. The main questions it aims to answer are: * Can…
Phase: PHASE4 • Sponsor: Cell Biopeutics Resources Sdn Bhd • Aim: Disease control
Last updated Jun 26, 2026 15:04 UTC